User Manual

Lumax Technical Manual 5
 Intraventricular conduction delay (QRS duration 130 ms)
The Lumax Implantable Cardioverter Defibrillators (ICDs) and
Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are
intended to provide ventricular anti-tachycardia pacing and
ventricular defibrillation, for automated treatment of life-
threatening ventricular arrhythmias.
1.3 Contraindications
The Lumax devices are contraindicated for use in patients with
the following conditions:
 Patients whose ventricular tachyarrhythmias may have
transient or reversible causes such as:
 Acute myocardial infarction
 Digitalis intoxication
 Drowning
 Electrocution
 Electrolyte imbalance
 Hypoxia
 Sepsis
 Patients with incessant ventricular fibrillation (VF) and
ventricular tachycardia (VT)
 Patients whose only disorder is brady arrhythmias or
atrial arrhythmias
1.4 Warnings and Precautions
MRI (Magnetic Resonance Imaging) - Do not expose a patient
to MRI device scanning. Strong magnetic fields may damage the
device and cause injury to the patient.
Electrical Isolation - To prevent inadvertent arrhythmia
induction, electrically isolate the patient during the implant
procedure from potentially hazardous leakage currents.
Left Ventricular Lead Systems – BIOTRONIK CRT-Ds may be
implanted with any legally marketed, compatible LV lead.
Compatibility is defined as:
 IS-1 pacing connector
 Active or passive fixation technology
 Insertion and withdrawal forces as specified by
ISO 5841-3 (IS-1)